Geode Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101M | Buy |
2,071,883
+1,025,979
| +98% | +$49.9M | 0.01% | 1020 |
|
|
2025
Q1 | $35.6M | Buy |
1,045,904
+45,036
| +4% | +$1.53M | ﹤0.01% | 1573 |
|
|
2024
Q4 | $39.4M | Sell |
1,000,868
-7,346
| -0.7% | -$289K | ﹤0.01% | 1581 |
|
|
2024
Q3 | $47.4M | Buy |
1,008,214
+35,196
| +4% | +$1.65M | ﹤0.01% | 1457 |
|
|
2024
Q2 | $52.6M | Buy |
973,018
+63,720
| +7% | +$3.44M | ﹤0.01% | 1329 |
|
|
2024
Q1 | $62M | Buy |
909,298
+25,569
| +3% | +$1.74M | 0.01% | 1206 |
|
|
2023
Q4 | $55.3M | Buy |
883,729
+33,791
| +4% | +$2.12M | 0.01% | 1280 |
|
|
2023
Q3 | $38.6M | Buy |
849,938
+15,331
| +2% | +$696K | ﹤0.01% | 1401 |
|
|
2023
Q2 | $46.9M | Buy |
834,607
+24,623
| +3% | +$1.38M | 0.01% | 1295 |
|
|
2023
Q1 | $36.6M | Buy |
809,984
+20,886
| +3% | +$945K | ﹤0.01% | 1402 |
|
|
2022
Q4 | $32.1M | Buy |
789,098
+24,422
| +3% | +$993K | ﹤0.01% | 1454 |
|
|
2022
Q3 | $50M | Buy |
764,676
+50,481
| +7% | +$3.3M | 0.01% | 1091 |
|
|
2022
Q2 | $43.4M | Buy |
714,195
+51,106
| +8% | +$3.11M | 0.01% | 1223 |
|
|
2022
Q1 | $41.6M | Buy |
663,089
+596,823
| +901% | +$37.5M | 0.01% | 1382 |
|
|
2021
Q4 | $5.02M | Buy |
66,266
+1,811
| +3% | +$137K | ﹤0.01% | 2900 |
|
|
2021
Q3 | $7.21M | Buy |
64,455
+600
| +0.9% | +$67.2K | ﹤0.01% | 2696 |
|
|
2021
Q2 | $10.3M | Sell |
63,855
-181
| -0.3% | -$29.3K | ﹤0.01% | 2431 |
|
|
2021
Q1 | $7.8M | Buy |
64,036
+11,536
| +22% | +$1.41M | ﹤0.01% | 2525 |
|
|
2020
Q4 | $8.04M | Buy |
52,500
+1,262
| +2% | +$193K | ﹤0.01% | 2307 |
|
|
2020
Q3 | $4.29M | Buy |
51,238
+3,839
| +8% | +$321K | ﹤0.01% | 2484 |
|
|
2020
Q2 | $3.48M | Buy |
47,399
+4,449
| +10% | +$327K | ﹤0.01% | 2528 |
|
|
2020
Q1 | $1.82M | Buy |
42,950
+3,716
| +9% | +$158K | ﹤0.01% | 2718 |
|
|
2019
Q4 | $2.39M | Buy |
39,234
+758
| +2% | +$46.2K | ﹤0.01% | 2905 |
|
|
2019
Q3 | $1.58M | Sell |
38,476
-224
| -0.6% | -$9.18K | ﹤0.01% | 3059 |
|
|
2019
Q2 | $1.82M | Buy |
38,700
+112
| +0.3% | +$5.27K | ﹤0.01% | 3011 |
|
|
2019
Q1 | $1.38M | Buy |
38,588
+3,615
| +10% | +$129K | ﹤0.01% | 3030 |
|
|
2018
Q4 | $999K | Sell |
34,973
-852
| -2% | -$24.3K | ﹤0.01% | 3114 |
|
|
2018
Q3 | $1.59M | Buy |
35,825
+330
| +0.9% | +$14.6K | ﹤0.01% | 3008 |
|
|
2018
Q2 | $2.09M | Buy |
35,495
+7,982
| +29% | +$469K | ﹤0.01% | 2834 |
|
|
2018
Q1 | $1.26M | Buy |
27,513
+525
| +2% | +$24K | ﹤0.01% | 3011 |
|
|
2017
Q4 | $633K | Buy |
26,988
+570
| +2% | +$13.4K | ﹤0.01% | 3274 |
|
|
2017
Q3 | $472K | Buy |
26,418
+8,032
| +44% | +$144K | ﹤0.01% | 3387 |
|
|
2017
Q2 | $294K | Sell |
18,386
-2,724
| -13% | -$43.6K | ﹤0.01% | 3546 |
|
|
2017
Q1 | $459K | Buy |
21,110
+2,760
| +15% | +$60K | ﹤0.01% | 3336 |
|
|
2016
Q4 | $371K | Buy |
+18,350
| New | +$371K | ﹤0.01% | 3384 |
|